Therapeutic Utility of Opioids for Restless Legs Syndrome.

about

Preface for the 3rd Clinical Update Sleep, 23rd February 2018, Royal College of Physicians, London, UK: year in review.

P2860

Q55191100-7AFDFF59-7313-4B18-894A-8E80B1AE50E2

P2860

Therapeutic Utility of Opioids for Restless Legs Syndrome.

Item

http://www.wikidata.org/entity/Q39154225

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Therapeutic Utility of Opioids for Restless Legs Syndrome.

@en

Therapeutic Utility of Opioids for Restless Legs Syndrome.

@nl

type

Item

label

Therapeutic Utility of Opioids for Restless Legs Syndrome.

@en

Therapeutic Utility of Opioids for Restless Legs Syndrome.

@nl

prefLabel

Therapeutic Utility of Opioids for Restless Legs Syndrome.

@en

Therapeutic Utility of Opioids for Restless Legs Syndrome.

@nl

P1476

Therapeutic Utility of Opioids for Restless Legs Syndrome.

@en

P2093

John W Winkelman

http://www.w3.org/2001/XMLSchema#string

Susan E Mackie

http://www.w3.org/2001/XMLSchema#string

P2860

The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group

Prevalence of restless legs syndrome in chronic kidney disease: a systematic review and meta-analysis of observational studies.

Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Restless legs syndrome prevalence and impact: REST general population study.

Opioids for chronic noncancer pain: a position paper of the American Academy of Neurology.

Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool.

CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.

Practice guideline summary: Treatment of restless legs syndrome in adults: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Opioid therapy for chronic pain.

Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute.

P2888

s40265-017-0773-6

P304

1337-1344

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40265-017-0773-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28616844

http://www.w3.org/2001/XMLSchema#string

Therapeutic Utility of Opioids for Restless Legs Syndrome.

about

P2860

P2860

Therapeutic Utility of Opioids for Restless Legs Syndrome.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698